Endothelial dysfunction in patients with rheumatoid arthritis and comorbidity
https://doi.org/10.14412/1996-7012-2017-4-25-29
Abstract
Rheumatoid arthritis (RA) and subclinical hypothyroidism (SHT) have close pathogenetic relationships, the synergism of which worsens the clinical course and increases the risk of visceral complications. Objective: to study the ultrasound parameters of endothelial dysfunction (ED) in patients with RA concurrent with SHT. Patients and methods: 139 patients with RA were divided into two groups: 1) 48 patients with RA; 2) 91 patients with RA concurrent with SHT. The ultrasound parameters of endothelial regulation of vascular tone were determined by intravascular ultrasonography using an ESAOTE MyLAB40 apparatus in accordance with the international guideline. Results and discussion. The study of endothelial regulation of vascular tone established that all the examinees with RA had ED that increased with the higher degree of activity and longer duration of RA. Patients with RA in the presence of SHT had more significant abnormalities in the ultrasound parameters of endothelial regulation of vascular tone and in the degree of ED, which increased with the longer duration and higher activity of the disease. The early detection and correction of comorbidity in patients with RA will reduce cardiovascular risk and improve quality of life.
About the Authors
A. K. Knyazeva
Saint Luke Lugansk State Medical University, Lugansk
Ukraine
Ukraine
E. B. Komarova
Saint Luke Lugansk State Medical University, Lugansk
Ukraine
Ukraine
N. G. Bludova
Saint Luke Lugansk State Medical University, Lugansk
Ukraine
Ukraine
References
1. Гордеев АВ, Галушко ЕА, Насонов ЕЛ. Концепция мультиморбидности в ревматологической практике. Научно-практическая ревматология. 2014;52(4):362-5 [Gordeev AV, Galushko EA, Nasonov EL. The concept of multimorbidity in rheumato-logic practice. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2014;52(4):362-5 (In Russ.)]. doi: 10.14412/1995-4484-2014-362-365.
2. Насонов ЕЛ. Ревматология: клинические рекомендации. 2-е изд. Москва: ГЭОТАР-Медиа; 2010. 345с. [Nasonov EL. Revmatologiya: klinicheskie rekomendatsii [Rheumatology: Clinical recommendations]. 2 nd ed. Moscow: GEOTAR-Media; 2010. 345p.].
3. Naranjo A, Sokka T, Descalzo MA, et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther. 2008;10(2):1-10. doi: 10.1186/ar2383
4. Попкова ТВ, Новикова ДС, Насонов ЕЛ. Рекомендации по снижению кардиоваскулярного риска у пациентов с воспалительными артритами (по материалам рекомендаций Европейской антиревматической лиги). Совpeменная ревматология. 2010;4(1):7-11 [Popkova TV, Novikova DS, Nasonov EL. Recommendations for reducing cardiovascular risk in patients with inflammatory arthritis (based on the recommendations of the EULAR). Sovpemennaya Revmatologiya = Modern Rheumatology Journal. 2010;4(1):7-11 (In Russ.)]. doi: 10.14412/1996-7012-2010-579.
5. Глазун ЛО, Оттева ЭН, Зеленева НВ. Особенности изменений сосудистого русла у больных ревматоидным артритом, взаимосвязь изменений с функциональным состоянием эндотелия. Ультразвуковая и функциональная диагностика. 2009;2:102-10 [Glazun LO, Otteva EN, Zeleneva NV. Features of changes in the vascular bed in patients with rheumatoid arthritis, the relationship of changes with the functional state of the endothelium. Ul'trazvukovaya i Funktsional'naya Diagnostika = Ultrasound and Functional Diagnostics. 2009;2:102-10 (In Russ).].
6. Новикова ДС, Попкова ТВ, Кириллова ИГ и др. Оценка кардиоваскулярного риска у больных ранним ревматоидным артритом в рамках исследования РЕМАРКА (предварительные данные). Научно-практическая ревматология. 2015;53(1):24-31 [Novikova DS,
7. Popkova TV, Kirillova IG, et al. Cardiovascular risk assessment in patients with early rheumatoid arthritis within the REMARCA study: preliminary data. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(1):24-31 (In Russ.)]. doi: 10.14412/ 1995-4484-2015-24-31.
8. Aubry MC, Kremers MH, Reinalda MC, et al. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J Rheumatol. 2007; 34:937-42.
9. Шестакова ТП. Субклинический гипотиреоз – современный взгляд на проблему. Русский медицинский журнал. 2016; 24(1):6-8 [Shestakova TP. Subclinical hypothyroidism – a modern view of the problem. Russkii Meditsinskii Zhurnal. 2016;24(1): 6-8 (In Russ.)].
10. Теплова ЛВ, Еремеева АВ, Байкова ОА, Суворова НА. Ревматические проявления гипотиреоза. Современная ревматология. 2017;11(2):47-53. [Teplova LV, Eremeeva AV, Baykova OA, Suvorova NA. Rheumatic manifestations of hypothyroidism. Sovremennaya Revmatologiya = Modern Rheumatology Journal. 2017;11(2):47-53 (In Russ.)].
11. Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010; 304(12):1365-74. doi: 10.1001/jama. 2010.1361
12. Raterman HG. Rheumatoid Arthritis: The link between thyroid dysfunction, cardiovascular disease and B cell targeting. Netherlands: Monnickendam; 2013. 198 р.
13. Tü remen EE, Сetinarslan B, Sahin T, et al. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocr J. 2011;58(5):349-54. doi: 10.1507/ endocrj.K10E-333
14. Лелюк ВГ, Лелюк СЭ. Ультразвуковая оценка состояния периферической артериальной системы в норме и при патологии. Методическое руководство. Москва; 2005. 40 с. [Lelyuk VG, Lelyuk SE. Ul'trazvukovaya otsenka sostoyaniya perifericheskoi arterial'noi sistemy v norme i pri patologii. Metodicheskoe rukovodstvo [Ultrasonic assessment of the peripheral arterial system in normal and pathological conditions. Methodical guidance]. Moscow; 2005. 40 p.].
15. Teir J, Koduri G, Meadows A. An audit of recording cardiovascular risk factors in patients with rheumatoid arthritis and systemic lupus erythematosus in centres in East Anglia and the South East. Rheumatology (Oxford). 2008;47(8):1252-4. doi: 10.1093/ rheumatology/ken232.
16. Dhingra S, Bansal MP. Attenuation of LDL receptor gene expression by selenium deficiency during hypercholesterolemia. Mol Cell Biochem. 2006;282:75-82. doi: 10.1007/ s11010-006-1266-1.
17. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med. 2004;141:764-70. doi: 10.7326/0003-4819-141-10-200411160-00007.
18. Насонов ЕЛ. Метотрексат при ревматоидном артрите – 2015: новые факты и идеи. Научно-практическая ревматология. 2015;53(4):421-33 [Nasonov EL. Methotrexate in rheumatoid arthritis – 2015: new facts and ideas. Nauchno-Prakticheskaya Revmatologiya = Rheumatology Science and Practice. 2015;53(4):421-33 (In Russ.)]. doi: 10.14412/1995-4484-2015-421-433.
19. Jabbar A, Pingitore A, Pearce SH, et al. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14(1):39-55. doi: 10.1038/nrcardio.2016.174.
20. Hase H, Ando T, Eldeiry L, et al. TNF-mediates the skeletal effects of thyroid-stimulating hormone. PNAS. 2006;103(34):12849-54. doi: 10.1073/pnas.0600427103.
21. Arpaci D, Karakece E, Tocoglu AG, et al. Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism. Ann Clin Lab Sci. 2016;46(6):601-7.
22. Floriani C, Gencer B, Collet TH, Rodondi N. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. Eur Heart J. 2017. doi: 10.1093/eurheartj/ehx050.
Review
For citations:
Knyazeva AK, Komarova EB, Bludova NG. Endothelial dysfunction in patients with rheumatoid arthritis and comorbidity. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2017;11(4):25-29. (In Russ.) https://doi.org/10.14412/1996-7012-2017-4-25-29
Views:
875
Email this article 